Tianda Pharma Announces 2022/23 Interim Results
Tianda Pharma Announces 2022/23 Interim Results

HONG KONG, Nov 25, 2022 – (ACN Newswire via SEAPRWire.com) – Tianda Pharmaceuticals Limited (“Tianda Pharma” or “the Group”; stock code: 0455.HK) today announced its interim results for the six months ended 30 September 2022 (“the Period”). During the Period, the Group adopted proactive marketing strategy and improved its results notably. Its revenue increased by... » read more

JBM Healthcare Announces FY2023 Interim Results
JBM Healthcare Announces FY2023 Interim Results

HONG KONG, Nov 25, 2022 – (ACN Newswire via SEAPRWire.com) – JBM (Healthcare) Limited (“JBM Healthcare” or the “Group”; Stock Code: 2161), a leading branded healthcare products marketer and distributor in Hong Kong, has announced today the interim results of the Group for the six months ended 30 September 2022 (the “Reporting Period”). KEY HIGHLIGHTS—... » read more

Kingworld Medicines Sees 2021 Profit Soar 159% to RMB30.3 Million
Kingworld Medicines Sees 2021 Profit Soar 159% to RMB30.3 Million

HONG KONG, Mar 30, 2022 – (ACN Newswire via SEAPRWire.com) – Kingworld Medicines Group Limited (stock code: 01110.HK), a leading omni-channel enterprise providing world-famous greater health products, announced today its audited consolidated results for the year ended 31 December 2021. Although the Group faced many uncertainties in 2021, it managed to achieve a significant recovery... » read more

Kingworld Medicines Group Issues Positive Profit Alert for 2021
Kingworld Medicines Group Issues Positive Profit Alert for 2021

HONG KONG, Mar 23, 2022 – (ACN Newswire via SEAPRWire.com) – Kingworld Medicines Group Limited (stock code: 01110.HK), a leading omni-channel enterprise providing greater health products and services in China, issued today a positive profit alert as it expects to record an approximately 155% to 160% increase in profit attributable to owners of the Company... » read more

JSP Pharmaceutical Manufacturing (SET: JP) debuts shares on MAI
JSP Pharmaceutical Manufacturing (SET: JP) debuts shares on MAI

Aims to be leader in R&D, production and distribution of medicines and nutritional supplements BANGKOK, Nov 2, 2021 – (ACN Newswire) – JSP Pharmaceutical Manufacturing (Thailand) PCL (SET: JP), a developer, manufacturer and distributor of modern and traditional medicines, herbal products and nutritional supplements, is debuting on the MAI today. JSP is ready to pursue growth through developing new... » read more